ArticleBMC cancer2025
Trends in cancer burden for adolescents and young adults in China from 1990 to 2021.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in breast cancer mortality and analysis of years of life lost among Chinese residents, 2013-2021.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCancer among adolescents and young adults (AYAs), defined as ages 15-39 years, is an increasing public health concern globally, characterized by unique epidemiological patterns and significant health and societal burdens. Despite rising evidence of its impact in China, a comprehensive assessment of the cancer burden remains Limited. This study aims to examine trends in the cancer burden among Chinese AYAs from 1990 to 2021.
methodsData were extracted from the Global Burden of Disease (GBD) 2021 study. The age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life year (DALY) rate (ASDR) per 100,000 population were calculated and stratified by sex, alongside risk-attributable burdens. Trends were examined using the estimated annual percentage change (EAPC) and joinpoint regression, and projections were made using auto-regressive integrated moving average models.
resultsFrom 1990 to 2021, the incidence of cancer among AYAs increased, with ASIR rising from 36.74 to 51.51 per 100,000 population. However, mortality decreased, with ASMR declining from 22.53 to 14.89 per 100,000 population, and the disability burden also decreased, with ASDR declining from 1,331.48 to 689.68 per 100,000 population. Breast cancer emerged as the leading contributor to incidence burden (ASIR: 6.03), while tracheal, bronchus, and lung cancers, along with leukemia, accounted for the highest mortality (ASMR: 1.73) and DALYs (ASDR: 98.73) burden among AYAs. Tobacco use and dietary risks were the largest contributors to the overall cancer burden, whereas unsafe sex remained the principal risk factor for cervical cancer.
conclusionsOur findings highlight a potentially increasing cancer burden among AYAs in China, primarily due to lifestyle, environmental, and infectious factors. Future prevention efforts should target both traditional risk factors and emerging lifestyle threats, with a focus on cancer prevention and screening for AYAs at high risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.